drugset / Trial / NCT04088851
"Hepatic Substrate Flux Rates in Type 2 Diabetes"
RandomizedCrossoverOpen-labelBasic science
Summary
Investigation of the effects of redox shuttle inhibition by metformin on gluconeogenic flux rates of lactate and glycerol in humans with type 2 diabetes
Timeline
- Start
- 2019-09-11
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 1 g | Oral |